Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at...
Clinical updates, including trial initiations, enrollment status and data readouts and publications:...
NVAX's COVID-flu combo shot sparks strong immunity in seniors, fueling plans for further late-stage ...
On Wednesday, June 11, 2025, Novavax Inc. (NASDAQ:NVAX) presented at the Goldman Sachs 46th Annual G...